Pradaxa tv commercials
TV spots
TV commercials Pradaxa
The Pradaxa TV Spot titled 'Aquarium' is a visually stunning advertisement that aims to showcase the efficacy of the blood-thinner drug- Pradaxa. The commercial begins with a male and female swimmer diving into an aquarium with various aquatic creatures swimming around them. As the swimmers approach...
Pradaxa is a blood-thinning medication that is commonly prescribed to patients who are at an increased risk of having blood clots. The Pradaxa TV spot, 'Dad', is an emotional and heartfelt commercial that focuses on the importance of keeping loved ones safe and healthy.The commercial begins with a f...
The TV spot for Pradaxa, known as 'Fish,' is a compelling and thought-provoking advertisement that captures the viewer's attention through its use of powerful imagery and emotive storytelling. In the ad, a man is seen fishing in a tranquil stream, enjoying the peacefulness and freedom of nature. Sud...
The Pradaxa TV Spot, 'Picnic' is an advertisement that promotes the use of Pradaxa as a blood-thinning medication. The ad showcases a family having a picnic in a beautiful, sunny park. As the family enjoys their time together, the voiceover explains that while warfarin, a common blood-thinning medic...
Actors
Actors who starred in Pradaxa commercials
What kind of company is Pradaxa?
Pradaxa is not a company, but rather a brand name for the medication dabigatran etexilate, which is developed and marketed by the pharmaceutical company Boehringer Ingelheim.
About Boehringer IngelheimBoehringer Ingelheim is a global pharmaceutical company headquartered in Ingelheim, Germany. Founded in 1885, it is one of the world's largest family-owned pharmaceutical companies. The company focuses on researching, developing, manufacturing, and marketing innovative medicines for human and animal health.
Boehringer Ingelheim's main areas of expertise include respiratory diseases, cardiovascular diseases, immunology, oncology, central nervous system disorders, and metabolic diseases. The company is committed to making significant contributions to the health and well-being of people and animals worldwide.
Pradaxa (dabigatran etexilate)Pradaxa, also known by its generic name dabigatran etexilate, is an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with certain conditions, such as atrial fibrillation. It works by inhibiting the activity of thrombin, a key enzyme involved in blood clotting.
Pradaxa gained FDA approval in 2010 and has since been widely prescribed as an alternative to warfarin, which had been the standard oral anticoagulant for decades. Pradaxa offers several advantages over warfarin, including fewer drug interactions, no need for regular blood monitoring, and a faster onset of action.
However, Pradaxa has also been associated with bleeding risks, particularly gastrointestinal bleeding. These concerns led to regulatory evaluations and lawsuits in the past, and Boehringer Ingelheim has settled some related litigations.
It's important to note that the information provided is based on general knowledge and the search results provided. For accurate and up-to-date information on Pradaxa and Boehringer Ingelheim, it is recommended to consult official sources or seek professional medical advice.
